cancer biology

Displaying 1 - 3 of 3


Grant bolsters research on myelodysplastic syndromes

Michael Savona, MD, professor of Medicine and Cancer Biology, and director of Hematology Research at Vanderbilt- Ingram Cancer Center, has received a competitive grant award from the Edward P. Evans Foundation.

The Discovery Research Grant (DRG) will support his work to develop therapies for patients with myelodysplastic syndromes, a group of cancers that occur when immature blood cells in the bone marrow don’t fully develop or fail to become healthy blood cells.


Breast cancer-killing RIG

Immune checkpoint inhibitors — cancer therapies that remove the “brakes” on the adaptive anti-tumor immune response — have had remarkable success in melanoma and lung cancer.